Decoding cardiorenal crosstalk: Intercellular communication mechanisms and therapeutic insights in cardiorenal

Miaomiao Wei1, Yuxiao Cao1, Lei Wei1

  • 1Department of Internal Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300380, China.

Iscience
|July 23, 2026
PubMed

Insights

Cardiorenal syndrome (CRS) involves linked heart and kidney damage. This review explores how cell communication disruptions drive CRS, suggesting new therapies targeting these pathways.

Area of Science:

  • Cardiology
  • Nephrology
  • Cell Biology
  • Pathophysiology

Background:

  • Cardiorenal syndrome (CRS) is a complex condition where heart and kidney dysfunction exacerbate each other.
  • Understanding the intricate cell-to-cell communication between cardiac and renal systems is crucial for managing CRS.
  • Existing knowledge gaps hinder the development of effective therapeutic strategies for CRS.

Purpose of the Study:

  • To systematically review the pathophysiological mechanisms of CRS focusing on intercellular communication.
  • To analyze physiological and pathological communication pathways between cardiac and renal cells in CRS.
  • To propose novel therapeutic strategies targeting cell communication in CRS.

Main Methods:

  • Systematic literature review of cardiorenal syndrome mechanisms.
  • Analysis of intercellular communication pathways, including soluble factors and extracellular vesicles.
  • Examination of communication in different CRS subtypes and reinterpretation of current therapies.

Main Results:

  • Identified key intercellular communication pathways (soluble factors, extracellular vesicles) driving CRS.
  • Detailed unique communication features across various CRS subtypes.
  • Reinterpreted existing therapies through the lens of cell communication regulation.

Conclusions:

  • Intercellular communication is central to cardiorenal syndrome pathophysiology.
  • Targeting cell communication pathways, using strategies like extracellular vesicle therapy and miRNA delivery, shows therapeutic promise.
  • Further research into these communication mechanisms is essential for advancing CRS treatment.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...